High expression of either gene was independently associated with reduced overall survival (OS) in ER+ breast cancer patients, although the correlation did not reach statistical significance (SLC1A2 HR = 1.53, P = 0.16, CD44 HR = 0.98, P = 0.93; Fig. 1 E).
← all excerpts
CD44 and SLC1A2 are commonly regulated but do not form a fusion transcript in ER+ breast cancer.
1
0.1600
0.1600